Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cytokinetics Inc. buy UBS Group AG

Cytokinetics Inc.
Start price
€74.42
29.06.26 / 50%
Target price
-
29.06.27
Performance (%)
-11.07%
Price
€66.18
18:36
Summary
This prediction is currently active. The price of Cytokinetics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.07%. This prediction currently runs until 29.06.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Cytokinetics Inc. -2.788% -2.788%
iShares Core DAX® 0.184% 5.072%
iShares Nasdaq 100 -0.770% -2.079%
iShares Nikkei 225® 0.733% -3.346%
iShares S&P 500 -0.166% 0.904%

Comments by UBS_Group_AG for this prediction

In the thread Discuss Cytokinetics Inc.

Cytokinetics (CYTK) was upgraded by UBS Group AG from "neutral" to "buy".
Ratings data for CYTK provided by MarketBeat

UBS Group AG 
0
Report Share
29.06.26 Buy -11.07%

Stopped prediction by UBS_Group_AG for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€34.60
03.04.23
€56.02
03.04.24
87.86%
04.04.24

UBS Group AG 
03.04.23 50%